Skip to main content
. 2016 Mar 8;17(2):139–144. doi: 10.1120/jacmp.v17i2.5980

Table 2.

Dose of PTVs and significance of differences for VMAT and IMRT plans (results are averaged for five patients)

V110%(%)
V105%(%)
V100%(%)
V95%(%)
D90(Gy)
IMRT
21.98±4.56
72.85±4.31
95.23±0.11
98.58±2.66
51.43±0.13
VMAT
7.18±4.78
55.65±3.91
95.38±1.40
99.30±2.93
51.23±0.21
t value 3.47 4.69 1.25 1.81 0.92
p value
<0.05
<0.05
>0.05
>0.05
<0.05
Dmax (Gy) Dmin (Gy) Dmean (Gy) HI CI
IMRT
57.28±0.44
47.98±0.45
53.66±0.21
0.17±0.02
0.64±0.39
VMAT
55.66±0.51
49.18±0.27
53.06±0.23
0.12±0.11
0.77±0.49
t value 2.93 4.36 2.67 5.32 8.40
p value
<0.05
<0.05
>0.05
<0.05
<0.05